Literature DB >> 15516491

Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A(2)-mediated surfactant dysfunction.

R Duncan Hite1, Michael C Seeds, Anca M Safta, Randolph B Jacinto, Julianna I Gyves, David A Bass, B Moseley Waite.   

Abstract

Pulmonary surfactant's complex mixture of phospholipids and proteins reduces the work of breathing by lowering alveolar surface tension during respiration. One mechanism of surfactant damage appears to be the hydrolysis of phospholipid by phospholipases activated in the inflamed lung. Humans have several candidate secretory phospholipase A(2) (sPLA(2)) enzymes in lung cells and infiltrating leukocytes that could damage extracellular surfactant. We considered two mechanisms of surfactant disruption by five human sPLA(2)s, including generation of lysophospholipids and the depletion of specific phospholipids. All five sPLA(2)s studied ultimately caused surfactant dysfunction. Each enzyme exhibited a different pattern of hydrolysis of surfactant phospholipids. Phosphatidylcholine, the major phospholipid in surfactant and the greatest potential source for generation of lysophospholipids, was susceptible to hydrolysis by group IB, group V, and group X sPLA(2)s, but not group IIA or IID. Group IIA hydrolyzed both phosphatidylethanolamine and phosphatidylglycerol, whereas group IID was active against only phosphatidylglycerol. Thus, with groups IB and X, the generation of lysophospholipids corresponded with surfactant dysfunction. However, hydrolysis of and depletion of phosphatidylglycerol had a greater correlation with surfactant dysfunction for groups IIA and IID. Surfactant dysfunction caused by group V sPLA(2) is less clear and may be the combined result of both mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516491     DOI: 10.1152/ajplung.00274.2004

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  22 in total

Review 1.  Therapeutic use of surfactant components in allergic asthma.

Authors:  Veit J Erpenbeck; Norbert Krug; Jens M Hohlfeld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

Review 2.  Multiple roles of phospholipase A2 during lung infection and inflammation.

Authors:  Bryan P Hurley; Beth A McCormick
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

3.  Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates.

Authors:  Daniele De Luca; Angelo Minucci; Domenico Tripodi; Marco Piastra; Domenico Pietrini; Cecilia Zuppi; Giorgio Conti; Virgilio P Carnielli; Ettore Capoluongo
Journal:  Intensive Care Med       Date:  2011-05-13       Impact factor: 17.440

4.  Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids.

Authors:  R Duncan Hite; Bonnie L Grier; B Moseley Waite; Ruud A Veldhuizen; Fred Possmayer; Li-Juan Yao; Michael C Seeds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-28       Impact factor: 5.464

5.  Pulmonary surfactant proteins and polymer combinations reduce surfactant inhibition by serum.

Authors:  Karen W Lu; Jesús Pérez-Gil; Mercedes Echaide; H William Taeusch
Journal:  Biochim Biophys Acta       Date:  2011-06-27

Review 6.  [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].

Authors:  S Lauer; L G Fischer; H D Stubbe; H Van Aken; M Westphal
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

7.  Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration.

Authors:  Daniele De Luca; Angelo Minucci; Enrico Zecca; Marco Piastra; Domenico Pietrini; Virgilio P Carnielli; Cecilia Zuppi; Ascanio Tridente; Giorgio Conti; Ettore D Capoluongo
Journal:  Intensive Care Med       Date:  2008-10-14       Impact factor: 17.440

8.  A non-BRICHOS surfactant protein c mutation disrupts epithelial cell function and intercellular signaling.

Authors:  Markus Woischnik; Christiane Sparr; Sunčana Kern; Tobias Thurm; Andreas Hector; Dominik Hartl; Gerhard Liebisch; Surafel Mulugeta; Michael F Beers; Gerd Schmitz; Matthias Griese
Journal:  BMC Cell Biol       Date:  2010-11-20       Impact factor: 4.241

9.  Sulforhodamine B and exogenous surfactant effects on alveolar surface tension under acute respiratory distress syndrome conditions.

Authors:  Tam L Nguyen; Carrie E Perlman
Journal:  J Appl Physiol (1985)       Date:  2020-09-24

10.  Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage.

Authors:  Daniele De Luca; Silvia Baroni; Giovanni Vento; Marco Piastra; Domenico Pietrini; Federica Romitelli; Ettore Capoluongo; Costantino Romagnoli; Giorgio Conti; Enrico Zecca
Journal:  Intensive Care Med       Date:  2008-07-22       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.